2017
Hormone producing gynecological tumors: pathologic entities and clinical significance
Boto AN, Hui P. Hormone producing gynecological tumors: pathologic entities and clinical significance. Expert Review Of Endocrinology & Metabolism 2017, 13: 9-24. PMID: 30063444, DOI: 10.1080/17446651.2018.1411799.Peer-Reviewed Original ResearchConceptsHormonal biomarkersGynecologic tumorsGynecologic neoplasmsOverproduction of hormonesAbnormal clinical manifestationsPatient treatment optionsGynecological organsNormal physiological settingsSerum hormonesClinical manifestationsGynecological tumorsTreatment optionsAbnormal elevationPathologic entityPathological diagnosisTherapeutic responseDisease progressionClinical significanceClinical utilityTreatment efficacyClinical monitoringHormonal productionHormonal productsTumorsHormone
2011
Clear Cell Cancer of the Uterine Corpus: The Association of Clinicopathologic Parameters and Treatment on Disease Progression
Varughese J, Hui P, Lu L, Yu H, Schwartz PE. Clear Cell Cancer of the Uterine Corpus: The Association of Clinicopathologic Parameters and Treatment on Disease Progression. Journal Of Oncology 2011, 2011: 628084. PMID: 22187554, PMCID: PMC3236522, DOI: 10.1155/2011/628084.Peer-Reviewed Original ResearchProgression-free survivalClear cell cancerOverall survivalCell cancerUterine cancerAggressive histologic subtypeRetrospective chart reviewSingle institution experiencePlatinum-based chemotherapyAdvanced-stage patientsSingle academic institutionAdjuvant therapyChart reviewFIGO stageWorse survivalUterine corpusClinicopathologic featuresHistologic subtypePoor prognosisTreatment regimensExcellent survivalDisease progressionTreatment strategiesClinicopathologic parametersInnovative therapies